Fundraising Fox
/People
Sign in

Dina Chaya

Investor

Partner, Private Equity at OrbiMed · Board director at Spruce Biosciences

London

Writes $100K – $5M checks · typically $1.5M

Find your path to Dina

819 people in our graph can introduce you to Dina.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Liam Flaherty to introduce you to Dina

You →Liam · together at Omega Funds (2022–2023) →Dina

Ask Jamie Chen to introduce you to Dina

You →Jamie · together at Omega Funds →Dina

Ask Sam Okafor to introduce you to Dina

You →Sam · 2 people · together at Invest Europe →Dina

Sign up to find every way you can get introduced to Dina

  • Your email: the people you already email who know Dina
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Dina
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Dina Chaya is a Partner on OrbiMed's Private Equity team, which she joined in 2023, and has worked in healthcare private equity and venture capital since 2001. Before OrbiMed, she held roles at Omega Funds, NeoMed, 3i, and Index Ventures. She holds a B.A. in Natural Sciences from the University of Cambridge and a Ph.D. in Molecular and Cellular Biology from Paris VI University, and is a CFA charterholder.

Invests in

BiotechDigital HealthHealthtech

Board director at Spruce Biosciences

Intro paths

→

In turn, Dina can intro founders to Spruce Biosciences's investors below.

Spruce Biosciences's investors · 8

AbingworthLondon · $15M – $30M checks · since 2025Aisling CapitalNew YorkHealthCapStockholm · since 2020Norwest Venture PartnersMenlo Park · $10M – $30M checks · since 2025Novo HoldingsCopenhagen · $1.1M – $54M checksOmega FundsBostonOrbiMedNew York · $1M – $75M checks · since 2020RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2020

Experience

  1. OrbiMedPartnercurrent2023 — presentLondon, United Kingdom
  2. Monks Investment Trust PLCBoard Director2022 — 2025
  3. Omega FundsPartner2017 — 2023
  4. NeoMedPartner2009 — 2023
  5. Invest EuropeMember of the Venture Capital Platform Council2018 — 2022
  6. 3i Group plcDirector Growth Capital / Venture Capital2004 — 2008
  7. Index VenturesAssociate2001 — 2004
  8. Fox Chase Cancer CenterPostdoctoral Fellow2000 — 2001
  9. Brown UniversityPostdoctoral Fellow1998 — 2000

Skills & more

Venture Capital29Private Equity22Start-ups14Investments12Pharmaceutical Industry3Growth Capital6Medical Devices6Due Diligence7Corporate Development13Valuation3MergersFunding3
+3 moreEntrepreneurshipBusiness StrategyInvestment Banking

From Dina's professional profile.

Deals · 1

Spruce BiosciencesBoard seat

via OrbiMed · filed Feb 2023 · $53.6M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at OrbiMed

Alexander M. Cooper
Investor at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Bill Moschella
Venture Partner at OrbiMed
Bob Smith
Investor at OrbiMed
Brendan Weber
Principal at OrbiMed

Network5

Alexandria Huynh
Analyst at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Brendan Weber
Principal at OrbiMed
Charles Steinman
Analyst at OrbiMed
Chau Khuong
Partner at OrbiMed

Investors connected to Dina in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dina Chaya?
Dina Chaya is a Partner on OrbiMed's Private Equity team, which she joined in 2023, and has worked in healthcare private equity and venture capital since 2001. Before OrbiMed, she held roles at Omega Funds, NeoMed, 3i, and Index Ventures. She holds a B.A. in Natural Sciences from the University of Cambridge and a Ph.D. in Molecular and Cellular Biology from Paris VI University, and is a CFA charterholder.
Where does Dina Chaya work?
Dina Chaya is Partner, Private Equity at OrbiMed and Board director at Spruce Biosciences.
What does Dina Chaya invest in?
Dina Chaya invests in Biotech, Digital Health, Healthtech.
What check size does Dina Chaya write?
Dina Chaya typically writes checks of $100K – $5M.
What boards does Dina Chaya sit on?
Dina Chaya holds tracked board seats at Spruce Biosciences.
Where did Dina Chaya go to school?
Dina Chaya studied at CFA Institute (Chartered Financial Analyst Degree, Finance); Pierre and Marie Curie University (PhD, Molecular & Cellular Biology of Development); Pierre and Marie Curie University (DEA, Molecular & Cellular Biology of Development).

Same school

Shared employers